August/September 2000
 |
| Features |
 |


 |
Transition to Adult Cystic Fibrosis Care |
| |
by Gwen McDonald, RN |
| |
A successful transition program includes the planned and orderly nature of the process, its initiation very early in adolescence, and its emphasis on the preparation of both the patient and the family. |
 |
 |
 |
Self-Monitoring Asthma at Home |
| |
by John Wolfe, RRT |
| |
Implementing preventive measures that focus on the patient's role in daily monitoring and managing asthma at home can prevent adverse outcomes. |
 |
 |
 |
Sleep Staging and Respiratory Scoring of Polysomnograms |
| |
by Thomas Kilkenny, DO, FAASM, and Steve Grenard, RRT |
| |
Time factors, presence or absence of eye movements, and the degree of chin muscle tone should be taken into account when determining a particular stage of sleep. |
 |
 |
 |
The Future of Prone Positioning in Adult Respiratory Distress Syndrome |
| |
by Jorge Pedroza, MD, and Guillermo Domínguez-Cherit, MD |
| |
While this maneuver can produce an increase in oxygenation, further studies are needed to determine its clinical value. |
 |
 |
 |
Lung-Volume-Reduction Surgery for Patients with End-Stage Emphysema |
| |
by Linda L. Kerby, RNC, MA |
| |
While LVRS has produced positive results in patients with emphysema, studies are still under way to establish concrete documentation. |
 |
 |
| |
CPAP |
 |
When to Discontinue Treatment |
| |
by Allen Boone, RPSGT |
| |
Physicians must ensure that patients receive continuous medical follow-up when deciding to discontinue CPAP treatment. |
 |
 |
 |
Emerging Antibiotic Resistance in Nosocomial Pathogens |
| |
by Lisa L. Dever, MD |
| |
It is critical that new antibiotics targeted at multidrug-resistant pathogens be used judiciously in order to preserve their usefulness. |
 |
 |
 |
Predicting Arterial Blood-Gas Results |
| |
by Paul Mathews, PhD, RRT, FCCM, FCCP, Larry Conway, RRT |
| |
Skilled and accurate assessment of arterial blood-gas results leads to successful diagnosis, intervention, and treatment planning for patients. |
 |
 |
 |
BIOCHIPS FOR ABG: New Technologies |
| |
by Valerie A. Kellogg, RRT, AAS, |
 |
 |
 |
Community-Acquired Pneumonia: An Update |
| |
by John D. Zoidis, MD |
 |
|
 |
 |
 |
 |
 |

 |
| Departments |
 |

|
|
|
 |
|